Trial intelligence / Profile preview

Pharmacokinetics of ceftriaxone in bone during hip replacement surgery

2006-004445-42Phase 4Active

Sponsor
Institute of Pharmacology and Toxicology
Start
Dec 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of ceftriaxone in osteomyelitis (OM), sponsored by Institute of Pharmacology and Toxicology. Primary endpoints: Bone and plasma pharmacokinetics of ceftriaxone and Criteria for development of improved prophylactic antibiotics. Started Dec 2006; status: active.

02

Drugs

ceftriaxone
03

Conditions

osteomyelitis (OM)

Beyond the preview

Go deeper on 2006-004445-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004445-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call